RPAM
CNCE

Rhenman & Partners Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Rhenman & Partners Asset Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-30,099
Closed -$420K – 112
2017
Q2 		$420K Hold
30,099
– – 0.06% 91
2017
Q1 		$513K Hold
30,099
– – 0.08% 85
2016
Q4 		$310K Hold
30,099
– – 0.06% 95
2016
Q3 		$304K Hold
30,099
– – 0.05% 95
2016
Q2 		$338K Buy
+30,099
New +$338K 0.06% 93